medulloblastoma - Robuta Search

https://publikationen.uni-tuebingen.de/xmlui/handle/10900/111674 Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells short term hedgehog signaling phosphoproteomics human medulloblastoma https://pubmed.ncbi.nlm.nih.gov/23567267/ Epigenetic Silencing of DKK3 in medulloblastoma Medulloblastoma (MB) is a malignant pediatric brain tumor arising in the cerebellum consisting of four distinct subgroups: WNT, SHH, Group 3 and Group 4, which... epigenetic silencing medulloblastoma https://pubmed.ncbi.nlm.nih.gov/29720672/ FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts Group 3 tumors account for 28% of medulloblastomas and have the worst prognosis. FTY720, an immunosuppressant currently approved for treatment of multiple... in group decreases medulloblastoma patient derived https://conservancy.umn.edu/items/aeeb58cf-6f43-4edf-8655-7bb246c2ab2e Maternal Folic Acid Supplementation and Risk of Medulloblastoma in Offspring Folate deficiency is reportedly the most common vitamin deficiency in the United States. Various clinical studies have researched the implications of such a... folic acid maternal supplementation risk medulloblastoma https://www.sciencedaily.com/releases/2024/07/240709184222.htm Study points at novel approach to treat Group 3 medulloblastoma | ScienceDaily A team of researchers has identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma (Gr3-MB) in the... study points novel approach https://eprints.ncl.ac.uk/299359 MDB-31. The clinical significance of sub-total surgical resection in childhood medulloblastoma: a... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-treatments-for-a-brain-tumour-called-medulloblastoma-hr-mb A trial comparing treatments for a brain tumour called medulloblastoma (HR-MB) This trial is comparing treatments after surgery for high risk medulloblastoma. It is for children and adults. comparing treatments for brain trial https://www.cruk.cam.ac.uk/publications/molecular-subgroups-of-medulloblastoma-the-current-consensus/ Molecular subgroups of medulloblastoma: the current consensus. - Cancer Research UK Cambridge... Authors: MD Taylor, PA Northcott, A Korshunov, M Remke, Y-J Cho, SC Clifford, CG Eberhart, DW Parsons, S Rutkowski, A Gajjar, DW Ellison, P Lichter, RJ... cancer research uk the current molecular subgroups medulloblastoma https://about.uq.edu.au/experts/project/37478 Exploiting CDK4/6 inhibition to treat medulloblastoma. | Project | UQ Experts exploiting inhibition treat medulloblastoma project https://www.news-medical.net/health/Sonic-Hedgehog-Medulloblastoma-Treatment.aspx Sonic Hedgehog Medulloblastoma Treatment Oct 11, 2022 - The occurrence of an SHH medulloblastoma is treated by the following steps... sonic hedgehog medulloblastoma treatment https://pubmed.ncbi.nlm.nih.gov/32553121/?dopt=Abstract DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma DEAD-Box Helicase 3 X-Linked (DDX3X) is frequently mutated in the Wingless (WNT) and Sonic hedghog (SHH) subtypes of medulloblastoma-the commonest malignant... susceptibility lineages medulloblastoma https://open.library.emory.edu/concern/publications/fd21003b-f442-4d90-9300-9029580629ac Medulloblastoma and the DNA Damage Response | OpenEmory Medulloblastoma and the DNA Damage Response dna damage response and the medulloblastoma https://www.cruk.cam.ac.uk/publications/phase-i-study-of-vismodegib-in-children-with-recurrent-or-refractory-medulloblastoma-a-pediatric-brain-tumor-consortium-study/ Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric... Authors: A Gajjar, CF Stewart, DW Ellison, S Kaste, LE Kun, RJ Packer, S Goldman, M Chintagumpala, D Wallace, N Takebe, JM Boyett, RJ Gilbertson, T Curran... phase i study https://eprints.ncl.ac.uk/216185 Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma... https://digitalcommons.wustl.edu/oa_4/5533/ "Salvage therapies for first relapse of SHH medulloblastoma in early ch" by Craig Erker, Mohamed S... BACKGROUND: Sonic hedgehog (SHH) medulloblastoma is the most common molecular group of infant and early childhood medulloblastoma (iMB) and has no standard of... https://amsdottorato.unibo.it/id/eprint/5547/ Effetti dell'inibizione di Tanchirasi in linee cellulari di Medulloblastoma umano effetti dell di linee cellulari https://www.researchandmarkets.com/report/global-medulloblastoma-drug-market Medulloblastoma Drug Market Size, Share & Forecast to 2030 The Medulloblastoma Drug Market, valued at USD 3.28B in 2026, is projected to reach USD 4.49B by 2030, growing at a 8.2% CAGR. market size medulloblastoma drug share forecast https://mbinitiative.org/ Cure for Childhood Medulloblastoma | The Medulloblastoma Initiative Apr 23, 2026 - The Medulloblastoma Initiative seeks a cure for childhood medulloblastoma by supporting life-changing scientific research. cure childhood medulloblastoma initiative https://pubmed.ncbi.nlm.nih.gov/15758008/?dopt=Abstract Treatment of early childhood medulloblastoma by postoperative chemotherapy alone Postoperative chemotherapy alone is a promising treatment for medulloblastoma in young children without metastases. early childhood treatment medulloblastoma postoperative chemotherapy https://www.ncl.ac.uk/press/articles/archive/2020/11/medulloblastomaresearch/ Medulloblastoma research - Press Office - Newcastle University A scientific breakthrough has enabled experts to predict relapse in a common childhood cancer and means doctors can tailor treatment for each individual child... press office medulloblastoma research newcastle university https://eprints.ncl.ac.uk/271005 The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic... clinical experience molecular landscape associated https://www.cruk.cam.ac.uk/publications/medulloblastoma-signalling-a-change-in-treatment/ Medulloblastoma: signalling a change in treatment. - Cancer Research UK Cambridge Institute Authors: RJ Gilbertson Journal name: Lancet Oncol Citation info: 5(4):209-218 Abstract: Medulloblastoma is the most common malignant brain tumour that occurs... cancer research uk in treatment medulloblastoma signalling change https://pubmed.ncbi.nlm.nih.gov/33502920/ Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma Clinical behavior of relapsed medulloblastoma must be contextualized in terms of up-front therapies and molecular classifications. Group 4 tumors exhibit... clinical outcomes patient matched molecular composition https://boris-portal.unibe.ch/entities/publication/42f61125-4d29-4a83-a0f8-7144fc751225 Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the... We investigated here the effects of S2T1-6OTD, a novel telomestatin derivative that is synthesized to target G-quadruplex-forming DNA sequences, on a... https://pubmed.ncbi.nlm.nih.gov/31763624/ Sox2+ cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest... https://pubmed.ncbi.nlm.nih.gov/40609543/ Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate... Leptomeningeal metastases are the most important source of morbidity and mortality for medulloblastoma patients. Radiation of the entire brain is highly... therapeutic radiation drives dissemination medulloblastoma https://dbbs.wustl.edu/tag/medulloblastoma/ medulloblastoma Archives - Division of Biology & Biomedical Sciences archives division medulloblastoma biology biomedical sciences https://open.library.emory.edu/concern/publications/3c6a9b7d-a50b-47e1-8329-ced0d36a42ff Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon... Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and... clinical outcomes https://pubchem.ncbi.nlm.nih.gov/bioassay/1671451 AID 1671451 - Drug screen in ICB984 medulloblastoma cells to determine synergistic drug... BioAssay record AID 1671451 submitted by Genome Instability in Tumors (B420) group, DKFZ: Drug screen in ICB984 medulloblastoma cells to determine synergistic... drug screen aid https://pure.psu.edu/en/publications/unusual-case-of-recurrent-extraneural-metastatic-medulloblastoma-/ Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: Durable complete... https://boris-portal.unibe.ch/entities/publication/b186005c-f14e-499c-bc04-897533b83e79 Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study... BACKGROUND Medulloblastoma is associated with rare hereditary cancer predisposition syndromes; however, consensus medulloblastoma predisposition genes have not... genetic predisposition a retrospective spectrum prevalence https://pubmed.ncbi.nlm.nih.gov/35438562/ MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study Background Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk stratification, which may aid therapeutic decision making, family... mri pediatric medulloblastoma multicenter study https://eprints.ncl.ac.uk/299358 MDB-64. Novel transcripts associate with survival in childhood medulloblastoma. - ePrints -... mdb novel transcripts associate https://www.ncbi.nlm.nih.gov/clinvar/RCV000440474.1/ NM_000546.6(TP53):c.818GA (p.Arg273His) AND Medulloblastoma - ClinVar - NCBI ClinVar archives and aggregates information about relationships among variation and human health. https://www.cruk.cam.ac.uk/publications/ddx3x-suppresses-the-susceptibility-of-hindbrain-lineages-to-medulloblastoma/ DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma. - Cancer Research UK... Authors: DM Patmore, A Jassim, E Nathan, RJ Gilbertson, D Tahan, N Hoffmann, Y Tong, KS Smith, T-D Kanneganti, H Suzuki, MD Taylor, P Northcott, RJ Gilbertson... https://pubmed.ncbi.nlm.nih.gov/28609654/ Intertumoral Heterogeneity within Medulloblastoma Subgroups While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterogeneity within subgroups is unknown. Similarity network... heterogeneity within medulloblastoma subgroups https://experts.mcmaster.ca/scholarly-works/3522801 ZIC1 is a context-dependent medulloblastoma driver... Learn about the scholarly work entitled ZIC1 is a context-dependent medulloblastoma driver... is a context dependent medulloblastoma driver https://scholars.uky.edu/en/publications/pediatric-medulloblastoma-drug-screens-and-preclinical-studies/ Pediatric medulloblastoma: Drug screens and preclinical studies - University of Kentucky drug screens preclinical studies university of pediatric medulloblastoma https://about.uq.edu.au/experts/project/44233 Suppression of tumorigenicity in medulloblastoma | Project | UQ Experts suppression medulloblastoma project uq experts https://www.cruk.cam.ac.uk/publications/pdgfrb-is-overexpressed-in-metastatic-medulloblastoma/ PDGFRB is overexpressed in metastatic medulloblastoma. - Cancer Research UK Cambridge Institute Authors: RJ Gilbertson, SC Clifford Journal name: Nat Genet Citation info: 35(3):197-198 DOI: http://doi.org/10.1038/ng1103-197 Research group: Gilbertson... cancer research uk metastatic https://about.uq.edu.au/experts/project/23979 A Synthetic lethal based approach for the treatment of medulloblastoma | Project | UQ Experts https://pubmed.ncbi.nlm.nih.gov/31582835/?dopt=Abstract EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor... Medulloblastoma (MB) is a malignant pediatric brain tumor for which new therapies are urgently needed. We demonstrate that treatment with EPZ-6438...